Certified Advisory Corp Palatin Technologies Inc Transaction History

Certified Advisory Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.5 $2,835 - $5,250	-10,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.44 - $0.63 $4,620 - $6,615	10,500 New	10,500 $5,000
Q2 2021 Aug 16, 2021	SELL	$0.48 - $0.72 $240 - $360	-500 Closed	0 $0
Q4 2017 Feb 22, 2018	BUY	$0.68 - $1.0 $340 - $500	500	500 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.64M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Certified Advisory Corp with notifications on news.